the future of cryptocurrency 2021- Top Top stories

In addition, the market value of Zhongwei Company, Weir Shares and UIH Medical all exceeded 100 billion yuan.According to the key industrial fields mentioned in the action plan, Shanghai's local semiconductor leading enterprises, pharmaceutical leading enterprises and new material leading enterprises are also expected to benefit from the merger and acquisition plan.Zhongwei company is a company engaged in the research, development, production and sales of high-end semiconductor equipment and pan-semiconductor equipment. Great Wall Securities said that the company's etching, thin film deposition and MOCVD equipment have reached the international advanced level.

According to data treasure statistics, excluding central enterprises and state-owned enterprises, among the above three sectors, there are 41 Shanghai local stocks with a market value exceeding 10 billion yuan.Analysts said that the plan is expected to benefit Shanghai local stocks from multiple dimensions.Shanghai state-owned shares have these.

Shanghai state-owned shares have these.As an economic and financial center, Shanghai has outstanding advantages in integrated circuits, biomedicine and new materials. The introduction of this merger and reorganization plan highlights Shanghai's determination to actively develop new quality productive forces and achieve autonomy and control.The stagflation stocks mainly include Haohaishengke, Shanghai Laishi and Weir. Among them, Haohai Shengke increased by less than 10%. The company is a scientific and technological innovative enterprise that applies biomedical materials technology and genetic engineering technology to research, develop, produce and sell medical devices and drugs. It is committed to providing innovative medical products for the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, and gradually realizing the import substitution of related medical products, thus becoming a leading enterprise in the field of biomedical materials.